The effectiveness of pancreatic enzyme replacement therapy for malabsorption in advanced pancreatic cancer, a pilot study
Palliative Care: Research and Treatment · 2019
DOI: 10.1177/1178224218825270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Palliative Care: Research and Treatment, 2019. Verfasst von Amanda Landers und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Otago, Christchurch New Zealand. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: canterbury medical research foundation.
Abstract (Originalsprache)
Advanced adenocarcinoma of the pancreas has a globally poor prognosis. One of the characteristic features of pancreatic cancer (PC) is pancreatic exocrine insufficiency (PEI). This leads to a malabsorption syndrome and subsequent digestive symptoms. Given the high prevalence of PEI and malabsorption in PC, empiric use of pancreatic enzyme replacement therapy (PERT) is recommended. The aim of this pilot study was to determine the potential efficacy of PERT in improving symptoms and quality of life in those with metastatic PC. The study recruited patients with advanced PC referred to a specialist palliative care service. Following an initial assessment, patients were commenced on pancrealipase 25,000IU (Creon) and reassessed after 1 week and 3 weeks post-initiation of supplementation. These assessments included demographics, malabsorption symptom checklist, and completion of two validated quality-of-life questionnaires, the European Organisation for Research and Treatment of Cancer QLQ-C30 and QLQ-PAN26. PERT was associated with statistically significant improvement of symptoms in both the general (QLQ-C30) and pancreatic cancer specific tool (PAN26). Within 1 week of PERT initiation, there was a reduction in diarrhoea scores (26 vs. 8, p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Otago, Christchurch New Zealand.
- Nurse Maude Hospice Palliative Care Service, Nurse Maude Association, Christchurch, New Zealand.
- Department of Medicine, University of Otago, New Zealand.
ORCID-Profile: Amanda Landers
Förderung
- canterbury medical research foundation
Zitieren
APA
Landers, A., Brown, H., & Strother, M. (2019). The effectiveness of pancreatic enzyme replacement therapy for malabsorption in advanced pancreatic cancer, a pilot study. Palliative Care: Research and Treatment. https://doi.org/10.1177/1178224218825270
Vancouver
Landers A, Brown H, Strother M. The effectiveness of pancreatic enzyme replacement therapy for malabsorption in advanced pancreatic cancer, a pilot study. Palliative Care: Research and Treatment. 2019. doi:10.1177/1178224218825270
BibTeX
@article{Landers2019,
author = {Landers, Amanda and Brown, Helen and Strother, Matthew},
title = {The effectiveness of pancreatic enzyme replacement therapy for malabsorption in advanced pancreatic cancer, a pilot study},
journal = {Palliative Care: Research and Treatment},
year = {2019},
doi = {10.1177/1178224218825270}
}
EUVIMED